These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22850516)

  • 1. Comparative pharmacokinetics of continuous and conventional intrathecal amphotericin B in rabbits.
    Fang M; Lü TM; Ma AD; Wang L; Li GL; Qiu AZ; Pan ZY; Wang YY; Liu XJ
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5253-7. PubMed ID: 22850516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of amphotericin B in the cerebrospinal fluid during continuous intrathecal administration for treatment of cryptococcal neoformans meningitis].
    Fang M; Lv TM; Yan Y; Liu ST; Gao WH; Liu XJ; Yin J; Wang L; Wang YY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1929-31. PubMed ID: 22126783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.
    Clemons KV; Sobel RA; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):612-5. PubMed ID: 11158765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
    Clemons KV; Sobel RA; Williams PL; Pappagianis D; Stevens DA
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2420-6. PubMed ID: 12121913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and pharmacokinetics of intrastromal injection of amphotericin B in a rabbit model.
    Qu L; Li L; Xie H
    Curr Eye Res; 2014 Apr; 39(4):340-7. PubMed ID: 24215098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.
    Strenger V; Meinitzer A; Donnerer J; Hofer N; Dornbusch HJ; Wanz U; Seidel MG; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urban C
    J Antimicrob Chemother; 2014 Sep; 69(9):2522-6. PubMed ID: 24891430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B.
    Kaji Y; Yamamoto E; Hiraoka T; Oshika T
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):549-53. PubMed ID: 19043733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration.
    Malone ME; Corrigan OI; Kavanagh PV; Gowing C; Donnelly M; D'Arcy DM
    Int J Antimicrob Agents; 2013 Oct; 42(4):335-42. PubMed ID: 23920093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases.
    Hong Y; Shaw PJ; Tattam BN; Nath CE; Earl JW; Stephen KR; McLachlan AJ
    Eur J Clin Pharmacol; 2007 Feb; 63(2):165-72. PubMed ID: 17180621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pharmacology of amphotericin B applied in lipid emulsions.
    Heinemann V; Kähny B; Jehn U; Mühlbayer D; Debus A; Wachholz K; Bosse D; Kolb HJ; Wilmanns W
    Antimicrob Agents Chemother; 1997 Apr; 41(4):728-32. PubMed ID: 9087478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trending serial CSF samples to guide treatment of refractory coccidioidal meningitis with intrathecal liposomal amphotericin.
    Fiani B; Nguyen A; Quadri SA; Farooqui M; Zafar A; Sodhi A; Kerkar S; Nacionales D; Fischberg GM
    Clin Neurol Neurosurg; 2019 Jun; 181():41-43. PubMed ID: 30986725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.
    Groll AH; Mickiene D; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2000 Feb; 44(2):408-10. PubMed ID: 10639371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Ophthalmic Res; 2004; 36(3):172-6. PubMed ID: 15103209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
    Gershkovich P; Wasan EK; Lin M; Sivak O; Leon CG; Clement JG; Wasan KM
    J Antimicrob Chemother; 2009 Jul; 64(1):101-8. PubMed ID: 19398459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.